This indicates that FCN2 has certain clinical importance, whether from the high and low FCN2 expression groups (median) or the expression analysis of normal liver tissue and different liver cancer subgroups, and could be a complementary gene for AFP detection in liver cancer. Here, AFP is linked to liver cancer.